Fig. 2

K-M analyses for study population according to CD47, PD-L1 expression, FIGO stage, and BRCA mutation. A PFS by CD47 expression categorized as high expression vs. low expression. B OS by CD47 expression categorized as high expression vs. low expression. C PFS by FIGO stage categorized as advanced stage vs. early stage. D OS by FIGO stage categorized as advanced stage vs. early stage. E PFS by PD-L1 expression categorized as positive expression vs. negative expression. F OS by PD-L1 expression categorized as positive expression vs. negative expression. G PFS by BRCA mutation status categorized as mutated type vs. wild type. H OS by BRCA mutation status categorized as mutated type vs. wild type